標靶DNA/RNA定序市場規模、佔有率和成長分析：按方法、產品、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球標靶 DNA 和 RNA定序市場價值為 75.2 億美元，預計到 2025 年將成長至 83.3 億美元，到 2033 年將成長至 188.5 億美元，在預測期（2026-2033 年）內複合年成長率為 10.82%。

全球標靶DNA/RNA定序市場日益專注於分析特定基因組區域的診斷服務，與全基因測序相比，它能以更低的成本提供更精準的基因資訊。精準醫療需求的不斷成長，尤其是在腫瘤學和遺傳疾病領域，正在推動市場成長，臨床醫生尋求快速獲得突變譜以輔助治療決策。從傳統的桑格定序到新一代定序平台，技術的進步為多重檢測和高效的商業解決方案鋪平了道路。推動市場擴張的關鍵因素包括保險公司對生物標記主導醫療的接受度，促使檢查室將標靶檢測納入其診斷流程。此外，人工智慧的進步提高了突變檢測的準確性，簡化了分析流程，並最終提升了處理能力和可靠性。這些技術與臨床需求的協同效應正在促進夥伴關係，並推動全球市場成長。

全球標靶DNA/RNA定序市場促進因素

全球標靶DNA和RNA定序市場的主要促進因素之一是遺傳疾病和癌症的日益普遍，這需要先進的診斷工具來制定有效的治療方案。隨著我們對疾病遺傳基礎的理解不斷加深，醫療專業人員越來越依賴標靶定序來識別遺傳物質中的特定突變和改變。定序技術的進步推動了這項需求，隨著定序準確性的提高和成本的降低，越來越多的檢查室能夠使用定序技術。此外，對個人化醫療的日益重視也加速了對患者特異性基因組評估的需求，進一步推動了市場成長。

全球標靶DNA/RNA定序市場的限制因素

全球標靶DNA/RNA定序市場面臨的主要限制因素之一是定序技術和必要基礎設施的高成本。先進的定序設備、試劑和數據分析工具的費用可能非常昂貴，限制了小規模實驗室和研究機構（尤其是在發展中地區）的使用。此外，操作先進定序技術和解讀複雜數據需要熟練的專業人員，這進一步增加了推廣應用的難度。這些資金和資源障礙會減緩市場創新和應用的步伐，阻礙標靶定序方法的更廣泛應用和發展。

全球標靶DNA/RNA定序市場趨勢

全球標靶DNA/RNA定序市場正經歷顯著成長，這主要得益於微創疾病檢測和監測所需的液態生物檢體技術的整合應用。這一趨勢已擴展到腫瘤學領域之外，在移植監測和感染疾病也得到了應用，導致對高靈敏度檢測方法和標準化方案的需求不斷成長。診斷技術開發商與臨床檢查室之間的合作日益密切，促使監管機構和保險公司建立相應的支援框架。此外，人們越來越重視改善檢體處理和標準化報告流程，這對於產生可靠的縱向數據至關重要，這些數據能夠支持循證實踐並為臨床決策提供基礎。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球標靶DNA/RNA定序市場規模：依方法分類

• 雜合反應捕獲
• 擴增子序列
• 分子反轉探針（MIPs）

全球標靶DNA/RNA定序市場規模：依產品類別分類

• 裝置
• 試劑和試劑盒
• 生物資訊軟體

全球標靶DNA/RNA定序市場規模：按應用領域分類

• 腫瘤生物標記檢測
• 遺傳疾病篩檢
• 感染疾病
• 藥物基因體學

全球標靶DNA/RNA定序市場規模：依最終用戶分類

• 研究機構
• 診斷實驗室
• 製藥和生物技術

全球標靶DNA/RNA定序市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina Inc.
• Thermo Fisher Scientific
• Qiagen NV
• Agilent Technologies
• Roche Diagnostics
• Pacific Biosciences
• Oxford Nanopore Technologies
• BGI Genomics
• Twist Bioscience
• Integrated DNA Technologies
• Foundation Medicine（Roche）
• Guardant Health
• Tempus Labs
• Grail Inc.
• NeoGenomics Laboratories
• Burning Rock Biotech
• Personal Genome Diagnostics
• Caris Life Sciences
• Genoptix（Novartis）
• Natera Inc.

結論與建議

Global Targeted Dna Rna Sequencing Market size was valued at USD 7.52 Billion in 2024 and is poised to grow from USD 8.33 Billion in 2025 to USD 18.85 Billion by 2033, growing at a CAGR of 10.82% during the forecast period (2026-2033).

The global targeted DNA/RNA sequencing market is increasingly focusing on diagnostic services that analyze specific genomic regions, providing precise genetic insights at lower costs compared to whole-genome sequencing. The rising demand for precision medicine, particularly in oncology and inherited disorders, drives market growth, as clinicians seek rapid mutation profiles to inform therapies. Advances from traditional Sanger sequencing to next-generation platforms have paved the way for multiplexed panels and effective commercial solutions. Key factors influencing expansion include payer acceptance of biomarker-driven care, encouraging labs to integrate targeted assays into their diagnostics. Furthermore, AI advancements are enhancing accuracy in variant detection and streamlining analysis processes, ultimately increasing throughput and reliability. This synergy between technology and clinical needs fosters partnerships and global market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Targeted Dna Rna Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Targeted Dna Rna Sequencing Market Segments Analysis

Global targeted dna rna sequencing market is segmented by method, product, application, end-user and region. Based on method, the market is segmented into Hybridization Capture, Amplicon Sequencing and Molecular Inversion Probes (MIPs). Based on product, the market is segmented into Instruments, Reagents & Kits and Bioinformatics Software. Based on application, the market is segmented into Oncology Biomarker Testing, Hereditary Disease Screening, Infectious Disease and Pharmacogenomics. Based on end-user, the market is segmented into Research Institutes, Diagnostic Labs and Pharma & Biotech. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Targeted Dna Rna Sequencing Market

One of the key market drivers for the global targeted DNA and RNA sequencing market is the rising prevalence of genetic disorders and cancers, which necessitates advanced diagnostic tools for effective treatment planning. As understanding of genetic bases for diseases deepens, healthcare professionals increasingly rely on targeted sequencing to identify specific mutations and alterations in genetic material. This demand is fueled by advancements in sequencing technologies, which enhance accuracy and reduce costs, making them accessible to a broader range of laboratories. Moreover, the growing emphasis on personalized medicine accelerates the need for tailored genomic assessments, further propelling market growth.

Restraints in the Global Targeted Dna Rna Sequencing Market

One significant restraint in the Global Targeted DNA RNA Sequencing Market is the high cost associated with sequencing technologies and the necessary infrastructure. The expenses related to advanced sequencing equipment, reagents, and data analysis tools can be prohibitively high, limiting accessibility for smaller laboratories and research institutions, particularly in developing regions. Additionally, the requirement for skilled personnel to operate sophisticated sequencing technologies and interpret complex data further complicates adoption. These financial and resource barriers can slow the pace of innovation and implementation in the market, hindering broader application and advancement in targeted sequencing methodologies.

Market Trends of the Global Targeted Dna Rna Sequencing Market

The Global Targeted DNA and RNA Sequencing market is witnessing significant growth driven by the integration of liquid biopsy technologies, facilitating minimally invasive disease detection and monitoring. This trend extends beyond oncology, finding applications in transplant surveillance and infectious diseases, thereby enhancing the demand for high-sensitivity assays and standardized protocols. Collaborative efforts between diagnostics developers and clinical labs are on the rise, motivating regulatory bodies and payers to establish supportive frameworks. Additionally, there is a heightened focus on improving sample processing and achieving reporting harmonization, which is crucial for generating reliable longitudinal data to inform clinical decision-making and support evidence-based practices.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Targeted DNA RNA Sequencing Market Size by Method & CAGR (2026-2033)

• Market Overview
• Hybridization Capture
• Amplicon Sequencing
• Molecular Inversion Probes (MIPs)

Global Targeted DNA RNA Sequencing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits
• Bioinformatics Software

Global Targeted DNA RNA Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology Biomarker Testing
• Hereditary Disease Screening
• Infectious Disease
• Pharmacogenomics

Global Targeted DNA RNA Sequencing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Research Institutes
• Diagnostic Labs
• Pharma & Biotech

Global Targeted DNA RNA Sequencing Market Size & CAGR (2026-2033)

• North America (Method, Product, Application, End-User)
  • US
  • Canada
• Europe (Method, Product, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Product, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Product, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Product, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine (Roche)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grail Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Burning Rock Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personal Genome Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caris Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genoptix (Novartis)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations